(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
4 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 10.63%
6.40% $ 1.830
Live Chart Being Loaded With Signals
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 1.15M |
Średni wolumen | 508 379 |
Kapitalizacja rynkowa | 117.94M |
EPS | $0 ( 2024-05-01 ) |
Następna data zysków | ( $-0.150 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.16 |
ATR14 | $0.00700 (0.38%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Koenig Scott | Buy | 40 000 | Stock Option (right to buy) |
2024-05-01 | Goldberg Mark Alan | Buy | 40 000 | Stock Option (right to buy) |
2024-05-01 | Pearson Timothy R | Buy | 40 000 | Stock Option (right to buy) |
2024-05-01 | King Rachel K. | Buy | 40 000 | Stock Option (right to buy) |
2024-05-01 | Andrews Patricia S | Buy | 40 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
29.99 |
Last 98 transactions |
Buy: 6 982 849 | Sell: 4 750 194 |
Wolumen Korelacja
GlycoMimetics Inc Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
LSXMA | 0.92 |
LSXMK | 0.917 |
FRST | 0.889 |
ESGRO | 0.88 |
FSFG | 0.868 |
BIB | 0.864 |
CERC | 0.856 |
AUTL | 0.855 |
IMCR | 0.853 |
BBH | 0.845 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
GlycoMimetics Inc Korelacja - Waluta/Towar
GlycoMimetics Inc Finanse
Annual | 2023 |
Przychody: | $10 000.00 |
Zysk brutto: | $-143 301 (-1 433.01 %) |
EPS: | $-0.580 |
FY | 2023 |
Przychody: | $10 000.00 |
Zysk brutto: | $-143 301 (-1 433.01 %) |
EPS: | $-0.580 |
FY | 2022 |
Przychody: | $74 925.00 |
Zysk brutto: | $-957 231 (-1 277.59 %) |
EPS: | $-1.780 |
FY | 2021 |
Przychody: | $1 160.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.230 |
Financial Reports:
No articles found.
GlycoMimetics Inc
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing GMI-1359, which targets e-selectin and a chemokine receptor for the treatment of cancers that affect the bone and bone marrow, including solid tumors. It also develops various other programs, including GMI-1687, an antagonist of E-selectin to treat vaso-occlusive crisis; and galectin-3 antagonists, a carbohydrate-binding protein. The company has a cooperative research and development agreement with the National Cancer Institute; and a collaboration and license agreement with Apollomics (Hong Kong) Limited for the development and commercialization of uproleselan and GMI-1687. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej